Fineotex Chemical Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/wreb85gwcb9gkjb8ax2ib1en.pdf

Key Takeaways


Demand & Volume Dynamics

Tibrewala: "Generally, what happens is there is a trend which continues for six months. If it's going down, it's going down for six months. If it's going up, it's going up for six months minimum. However, this was the time when we are seeing fluctuations, like, one week, you start booking your products and raw materials. By the next week, you will see that it's gone up or it's gone down."

Margin Resilience & Input Volatility

Tibrewala: "Luckily, as you know, we are into speciality chemicals. And for the last 54 quarters of being listed, you might have seen our EBITDA have always been at least 18% for any of the quarters from 2011 from the time we have got listed."

The Fixed-Fare Model

Tibrewala: "Instead of, like the taxi meter, we are doing a fixed fare approach in which they are more satisfied about their cost."

Oil & Gas: Early Exports, Big Ambition


Acquisition: Advanced Talks, No Clock

Tibrewala: "We would never like to buy distressed assets or anything like that because we believe that we are not those, with experience of that."
Tibrewala: "If some deal in inorganic acquisition doesn't go well, it's not only you lose money, but you use lose your important 5 years of the -- how do I say, the specialty chemical cycle, I would say. Time is also very much important than money."

Capacity, Credit & People


Guidance & Commitments

CommitmentSpecificsTimeline
Ambernath Phase 1 operationalShift product lines from Mahape/Navi Mumbai; faster reaction technology for better costBeginning of next financial year (Q1 FY26)
Promoter warrant paymentRemaining ~₹33-33.5 crore to be paidApproximately 12 months from now (within 18 months of allotment)
Revenue CAGRAt least 28-30% CAGRComing couple of years
H2 vs H1 performanceH2 "definitely much better" than H1 across all businessesH2 FY25
Health & hygiene recoveryWill revive "very quickly"No date; management "not pessimistic"
Acquisition announcementAdvanced diligence; funds ready; disciplined approachNo specific quarter committed

Key Metrics

MetricQ2 FY25
Consolidated revenue₹145.7 crore, growth of ~3% compared to Q1 FY2025
Profit after tax₹32.1 crore, growth of ~10% compared to Q1 FY2025
PAT margin22%
EBITDA margin~25%
Gross margin35% to 40% range maintained over last six years
Textile division volume growth~14% to 15% QoQ and ~17% to 18% YoY
Health and hygiene volumesdown ~10% to 15% with lower realizations
H1 volumes~33,000 to 34,000 tons, largely flattish H1 over H1
Exports share of revenue~30%, up from ~24% to 25%
R&D budget outflow~₹7 crore to ₹8 crore
Total fund-raise this year₹342.55 crore
Fund-raise via preferential allotment₹218 crore through equity shares and commodity warrants
Promoter participation in fund-raise₹45 crore, with ~₹11.5 to 12 crore already paid
Products under ZDHC and GOTS ecological approvalscrossed 250
Ambernath Phase 1 capacity18,000 to 20,000 tons, expected operational by beginning of next financial year